Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Goldspiel

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbineJame Abraham, Maureen Edgerly, Richard Wilson, et al.
Molecular Genetics and Metabolism|June 24, 2017
Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathyXin Xu, Amy Q Wang, Lea L Latham, et al.
Clinical Pharmacology and Therapeutics|February 3, 2018
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 UpdateElizabeth J Phillips, Chonlaphat Sukasem, Michelle Whirl-Carrillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasmsVictor Sandor, Susan Bakke, Robert W Robey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinomaSusan E Bates, Susan Bakke, Min Kang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbineJame Abraham, Maureen Edgerly, Richard Wilson, et al.
Molecular Genetics and Metabolism|June 24, 2017
Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathyXin Xu, Amy Q Wang, Lea L Latham, et al.
Clinical Pharmacology and Therapeutics|February 3, 2018
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 UpdateElizabeth J Phillips, Chonlaphat Sukasem, Michelle Whirl-Carrillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasmsVictor Sandor, Susan Bakke, Robert W Robey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinomaSusan E Bates, Susan Bakke, Min Kang, et al.
Pageof 1